Nasdaq:US$16.69 (+0.86) | HKEX:HK$25.75 (+0.70) | AIM:£2.67 (+0.07)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 1 Apr 2014

AACR 2014: Targeting MET in preclinical models to support the clinical development of AZD6094/HMPL-504 (savolitinib) in NSCLC